NCT07764172Recruiting
Sarcopenia in Acute Ischemic Stroke
Sarcopenia in Patients During the Acute Phase of Ischemic Stroke: Multimodal Assessment and Three-Month Functional Outcomes
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
The objective of this observational study is to determine the prevalence of sarcopenia in patients aged 50 years and older with acute ischemic stroke, to characterize its trajectory during the acute phase using instrumental verification and functional-cognitive assessments, and to evaluate its impact on functional outcome at three months. The main research question is: Is the presence of sarcopenia at admission associated with less favorable stroke outcomes, including higher rates of complications and mortality? Participants receiving standard medical care for acute ischemic stroke will undergo extended functional assessment for sarcopenia, and a subset will additionally undergo cognitive evaluation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 4 Aug 2026
- Start date
- 1 Aug 2026
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)
- Diseases
- Stroke
- NCT number
- NCT07764172
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Aug 2026 to the primary completion date, 31 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active cancer at stage IV or life expectancy of less than 3 months
- Neuromuscular diseases; chronic use of systemic glucocorticoids for more than 3 months
Other
- TIA without a visible lesion on neuroimaging; bilateral hemiparesis
- Amputations or severe contractures that preclude anthropometric assessment
- Pregnancy; refusal to participate
- Discontinuation criteria (drop-out)
- Discharge or death within the first 7 days
- Withdrawal of consent
- Transfer to another facility resulting in loss of contact
Who the study is looking for
- Age 50 years and older
- Acute ischemic stroke confirmed by CT or MRI
- Admission within the first 72 hours
- Written informed consent and availability of a contact telephone number for follow-up
Age in the registry: 50 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Moscow State Budgetary Healthcare Institution "Moscow City Hospital named after S.S. Yudin, Moscow Healthcare Department" Coordinator of this site? Confirm its status | Moscow | Russia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.